Shandong Orient Pharma Co., Ltd.

Language ▼

Chinese

English

Russian

Brazil

Spanish

Menu
  • Home
  • Products
    • API (Human & Veterinary)
      • Cardiovascular API
      • Gastrointestinal API
      • Anti-Infective API
      • Veterinary API
      • Endocrine & Thyroid API
      • Respiratory API
      • CNS & Nervous System APIs
      • Vitamins & Nutrition APIs
      • Other Therapeutics API
      • Hepatobiliary & Gastrointestinal APIs
      • Musculoskeletal & Nutrition APIs
      • Anticoagulant & Antithrombotic APIs
      • Oncology API
      • Urology & Men's Health APIs
      • Anti-inflammatory, Immunology, Pain & Dermatology APIs
      • Infusion & Plasma Volume APIs
      • Diabetes & Metabolic APIs
      • Ophthalmology & Anti-inflammatory APIs
      • Hemostatic API
    • Pharmaceutical Excipients
      • Pharmaceutical Excipients
    • Oral Dosing Systems
      • Oral Dosing Systems
    • Pharmaceutical Packaging Materials
      • Pharmaceutical Packaging Materials
    • Packaging Components
      • Pharmaceutical Rubber Closures Series
      • Aluminum Cover Series
      • Capsule Series
      • PVC And FOIL Series
      • Cleanroom Panel Series
    • Health Supplements
      • Health Supplements
  • About Us
  • Contact Us
  • Company News
Shandong Orient Pharma Co., Ltd.
Shandong Orient Pharma Co., Ltd. © 2026 All Right Reserved

Company News

Home > Company News

Deepening Global Market Expansion & Empowering International Layout | SHANDONG ORIENT Showcases Strength at Global Pharmaceutical Exhibitions

2026-08-28

To further expand global market channels, deepen international industry exchanges and enhance overseas brand influence, our company has continued to explore the global pharmaceutical and related industries this year. By actively participating in authoritative industry exhibitions across multiple countries, we steadily advance our global brand layout and fully demonstrate our product strength and innovative achievements.


As part of this year’s overseas exhibition strategy, we secured an independent booth at Expofarma Mexico. This participation enabled us to engage face-to-face with industry clients and partners across Latin America, tap into local market potential, and showcase our core products, technological advantages and customized solutions, effectively boosting our brand exposure and recognition in the Latin American pharmaceutical market.


Meanwhile, to keep abreast of cutting-edge global industry trends and benchmark against international advanced technologies, our team has conducted in-depth study and business communication at a series of influential global exhibitions, including CPHI Japan, CPHI Korea, TIHE Uzbekistan and FCE Brazil. We have gained comprehensive insights into regional industry policies, market demands, technological upgrading directions and emerging industry trends. In-depth exchanges with global peers and supply chain enterprises have helped us accumulate high-quality industry resources and provide solid support for product iteration and localized market adaptation.


Our global expansion momentum continues to accelerate. We are scheduled to attend CPHI Milan in the follow-up stage. By leveraging this world-class exhibition platform, we will further cultivate the core European market, build efficient cross-border communication channels, expand European market coverage, and strengthen our brand visibility and industry influence in Europe.


In line with our long-term global development strategy, we maintain annual regular booth participation in Moscow exhibitions to continuously explore the Russian and Eastern European markets. Through years of consistent exhibition attendance and one-on-one client communication, we have built stable customer resources and a solid market reputation, laying a firm foundation for our development in Eastern Europe.


Our multi-point exhibition coverage spanning Latin America, Central Asia, Japan, South Korea, Brazil, Europe and Eastern Europe fully embodies the solid implementation of our globalization strategy. In the future, we will continue to take global exhibitions as a key link, focus on product innovation and quality improvement, deeply cultivate global segmented markets, and strengthen international industry cooperation. We will keep expanding our overseas business territory and demonstrate the craftsmanship and core competitiveness of Chinese enterprises to global clients with professional strength, high-quality products and comprehensive services.

上一篇:没有了下一篇:没有了
底部LOGO

Services

  • Home
  • Products
  • About Us
  • Contact Us
  • Company News

Contact

  • WHATSAPP: +86 18289477061(Russia)
    +55(11)993336925(Latin America)
    +86 15006888368(Europe & America, Indonesia, South Korea, etc.)
    +81 70-9182-2487(Japan)
  • EMAIL : bruce@sanor-biotech.com
    maxim@sanor-biotech.com
    julio@sanor-biotech.com

Message

Please leave your information and we will contact you as soon as possible
© 2026 Shandong Orient Pharma Co., Ltd.  All Rights Reserved. Powered By TengYun